Ovarian activity before and after gonadal suppression by GnRH-a in patients with polycystic ovary syndrome, hyperandrogenism, hyperinsulinism and acanthosis nigricans.
OBJECTIVE
To investigate the ovarian activity before and after gonadal suppression with GnRH-analog in patients with PCO, hyperandrogenism, hyperinsulinism and acanthosis nigricans.


METHODS
Controlled clinical study.


METHODS
Tertiary academic medical center.


METHODS
Six patients with clinical findings of PCO, hirsutism and acanthosis nigricans.


METHODS
Morning blood samples in the follicular phase to determine the steroid levels, glucose and insulin curve, comparing to a control group. Administration for 2 consecutive months of a GnRH-analog, comparing, in the study group, the free testosterone levels before and after ovarian suppression.


METHODS
Determination of insulin levels in PCO, hirsutism and acanthotic patients and the free-testosterone levels before and after gonadal suppression.


RESULTS
Insulin levels were significantly higher in the study group when compared to normal women during the glycemic test. We also found a significant decrease in the free-testosterone levels after 2 months of gonadal suppression with GnRH-analog when compared to the initial time.


CONCLUSIONS
Patients with PCO, hirsutism and acanthosis nigricans present high levels of insulin, suggesting an ovarian hyperesponsiveness, which is not sustained when gonadotrophic blockage was achieved.
Motta
E L
EL
Department of Gynecology, Universidade Federal de São Paulo, Brazil.
Baracat
E C
EC
Haidar
M A
MA
Juliano
I
I
Lima
G R
GR
D000052:Acanthosis Nigricans / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D004700:Endocrine System Diseases / Q000378:metabolism*; D005260:Female; D005951:Glucose Tolerance Test; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000032:analysis*; D006801:Humans; D017588:Hyperandrogenism / Q000378:metabolism; D006946:Hyperinsulinism / Q000378:metabolism; D007328:Insulin / Q000032:analysis; D010053:Ovary / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000378:metabolism*
D007328:Insulin; D007987:Gonadotropin-Releasing Hormone